AVITA Medical Inc
General ticker "RCEL" information:
- Sector: Health Care
- Industry: Biotechnology
- Capitalization: $323.5M
AVITA Medical Inc does not follow the US Stock Market performance with the rate: -2.7%.
Estimated limits based on current volatility of 2.9%: low 11.37$, high 12.04$
Factors to consider:
- Current price 41.5% above estimated high
- Earnings for 18 months up through Q2 (+1 year) are below our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2022-12-31 to 2024-12-30
- 2022-12-31 to 2023-12-31 estimated range: [4.53$, 8.54$]
- 2023-12-31 to 2024-12-30 estimated range: [4.35$, 8.31$]
Short-term RCEL quotes
Long-term RCEL plot with estimates
Financial data
| YTD | 2022-12-31 |
|---|---|
| Operating Revenue | $37.64MM |
| Operating Expenses | $65.14MM |
| Operating Income | $-27.50MM |
| Non-Operating Income | $0.88MM |
| R&D Expense | $20.35MM |
| Income(Loss) | $-26.63MM |
| Taxes | $0.04MM |
| Profit(Loss) | $-26.66MM |
| Stockholders Equity | $84.74MM |
| Inventory | $3.12MM |
| Assets | $98.26MM |
| Operating Cash Flow | $-19.09MM |
| Capital expenditure | $0.66MM |
| Investing Cash Flow | $-19.33MM |
| Financing Cash Flow | $0.90MM |
| Earnings Per Share* | $-1.57 |
* EPS are Split Adjusted, recent splits may be reflected with a delay.